\-\ Texto\\:\\ \ \(0\)\
\-\ v\\/s\\ unremarkable\\.\\ \\ va\\ in\\ os\\ eye\\-\\ could\\ not\\ be\\ tested\\ with\\ snellen\\ but\\ appeared\\ able\\ to\\ see\\ small\\ pictured\\ objects\\.\ \(0\)\
\-\ l\\ periorbital\\ area\\:\\ noted\\ to\\ have\\ a\\ large\\ mass\\ as\\ noted\\ in\\ attached\\ picture\\.\\ \\ the\\ orbit\\ was\\ filled\\ with\\ gauze\\.\\ \\ \ \(0\)\
\-\ neuro\\:\\ cn\\ exam\\-\\ i\\ not\\ tested\\.\\ \\ ii\\ in\\ os\\ eye\\ grossly\\ unremarkable\\.\\ iii\\,\\ iv\\,\\ vi\\ in\\ os\\ eye\\ unremarkable\\.\\ \\ v\\,\\ vii\\-\\ sensation\\ absent\\ over\\ mass\\ lesion\\.\\ \\ able\\ to\\ wrinkle\\ forehead\\ bilaterally\\.\\ \\ smile\\ symmetrical\\.\ \(0\)\
\-\ viii\\,\\ ix\\,\\ x\\-\\ r\\ ear\\ was\\ occluded\\ with\\ cerumen\\ with\\ some\\ involvement\\ of\\ the\\ mass\\ of\\ the\\ anterior\\ ear\\ canal\\.\\ \\ tongue\\ and\\ palatal\\ movement\\ unremarkable\\.\ \(0\)\
\-\ a\\/p\\ squamous\\ cell\\ ca\\ vs\\ basal\\ cell\\ ca\\ vs\\ melanoma\\ vs\\ \\?\\ \\ we\\ had\\ the\\ xx\\ transport\\ the\\ patient\\ to\\ the\\ local\\ hospital\\,\\ but\\ the\\ patient\\ states\\ he\\ has\\ already\\ been\\ there\\ and\\ was\\ told\\ there\\ was\\ nothing\\ that\\ could\\ be\\ done\\.\\ \\ due\\ to\\ the\\ vacularity\\ in\\ a\\ ca\\ lesion\\,\\ i\\ suspect\\ that\\ any\\ debulking\\ surgery\\ would\\ meet\\ high\\ morbidity\\ and\\ mortality\\.\ \(0\)\
\-\ it\\ appears\\ that\\ the\\ lids\\ are\\ consumed\\ by\\ a\\ diffusely\\ infiltrative\\ neoplastic\\ process\\,\\ with\\ areas\\ of\\ marked\\ thickening\\,\\ ulceration\\ and\\ necrosis\\,\\ giving\\ the\\ appearance\\ of\\ a\\ rodent\\ ulcer\\.\ \(1\)\
\-\ squamous\\ cell\\ carcinoma\ \(52\)\
\-\ squamous\\ cell\\ carcinoma\ \(52\)\
\-\ basal\\ cell\\ carcinoma\ \(6\)\
\-\ primary\\ melanoma\ \(3\)\
\-\ lymphoma\\/leukemia\\,\\ leiomyosarcoma\\/leiomyoma\ \(2\)\
\-\ optic\\ nerve\\ tumor\\ \\(glioma\\)\ \(1\)\
\-\ meningioma\\,\\ schwannoma\\,\\ neurofibroma\ \(0\)\
\-\ lacrimal\\ tumors\\ etc\\,\\ vs\\ metastatic\\ lesion\\ \\(smoker\\?\\ lung\\)\\ paranasal\\ sinus\\ tumor\\ invasion\\.\ \(0\)\
\-\ lower\\ on\\ the\\ ddx\\:\\ sebaceous\\ cell\\ carcinoma\\,\\ other\\ adenocarcinoma\\,\\ granular\\ cell\\ tumor\\,\\ langerhans\\ histiocytosis\\,\\ fibrous\\ histiocytoma\\,\\ granulocytic\\ sarcoma\\,\\ myeloma\\,\\ osteosarcoma\\,\\ sarcoidosis\\,\\ amyloid\\ nodular\\,\\ hemangiopericytoma\\.\ \(0\)\
\-\ a\\ 60\\+\\ y\\/o\\ male\\ with\\ an\\ left\\ periorbital\\ mass\\.\\ \\ with\\ the\\ use\\ of\\ a\\ medical\\ interpreter\\,\\ i\\ slowly\\ was\\ able\\ to\\ collect\\ a\\ basic\\ history\\.\\ approximately\\ 12\\ to\\ 18\\ months\\ prior\\ to\\ presentation\\,\\ the\\ patient\\ states\\ he\\ had\\ a\\ \\"small\\ bump\\ around\\ his\\ left\\ eye\\"\\.\\ \\ due\\ to\\ poor\\ medical\\ resources\\ in\\ xx\\,\\ the\\ patient\\ states\\ he\\ traveled\\ to\\ yy\\ where\\ he\\ had\\ surgery\\.\\ \\ his\\ eye\\ was\\ surgically\\ removed\\ and\\ he\\ stated\\,\\ \\"no\\ cancer\\"\\.\\ \\ he\\ returned\\ to\\ xx\\ from\\ yy\\ and\\ states\\ the\\ small\\ lesion\\ slowly\\ grew\\ into\\ what\\ was\\ noted\\ on\\ exam\\ today\\.\\ \\ the\\ lesion\\ bleeds\\,\\ but\\ is\\ minimally\\ painful\\.\\ \\ he\\ states\\ he\\ has\\ been\\ having\\ progressively\\ worsening\\ right\\ sided\\ temporal\\ headaches\\.\ \(0\)\
\-\ pmhx\\:\\ none\\ reported\\ \\ \\ \\ \\ pshx\\:\\ enucleation\\ surgery\\ od\\ eye\ \(0\)\
\-\ rx\\:\\ none\\ \\ \\ \\ all\\:\\ nkda\ \(0\)\
\-\ 1st\\ ophthalmologist\\&\\#39\\;s\\ recommendation\\ \\/\\ dx\ \(0\)\
\-\ it\\ looks\\ like\\ advanced\\ squamous\\ cell\\ carcinoma\\ \\(less\\ likely\\ basal\\ cell\\ carcinoma\\.\\ given\\ the\\ advanced\\ stage\\ it\\ is\\ likely\\ that\\ it\\ has\\ metastasized\\.\\ it\\ could\\ be\\ debulked\\,\\ but\\ there\\ is\\ no\\ curative\\ surgery\\.\\ he\\ could\\ try\\ chemotherapy\\,\\ but\\ the\\ chances\\ for\\ success\\ are\\ slim\\.\ \(0\)\
\-\ if\\ it\\ is\\ basal\\ cell\\ ca\\ it\\ rarely\\ metastasizes\\ and\\ he\\ could\\ have\\ mohs\\ surgery\\ to\\ remove\\ the\\ tumor\\.\\ \\ \\ i\\ would\\ take\\ a\\ generous\\ biopsy\\ and\\ send\\ it\\ to\\ pathology\\.\\ if\\ it\\ is\\ squamous\\ cell\\ ca\\ i\\ would\\ refer\\ to\\ palliative\\ care\\.\\ if\\ it\\ is\\ basal\\ cell\\ ca\\ then\\ he\\ could\\ be\\ referred\\ to\\ oculoplastics\\ and\\ have\\ surgery\\.\\ \ \(0\)\
\-\ \\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\ \(3\)\
\-\ 1st\\ dermatologist\\â\\€\\™s\\ recommendation\\ \\/\\ dx\ \(0\)\
\-\ i\\ agree\\ with\\ dr\\.\\ xx\\.\\ we\\ need\\ a\\ biopsy\\ first\\.\\ do\\ you\\ have\\ any\\ imaging\\ capabilities\\ at\\ your\\ camp\\,\\ or\\ access\\ somewhere\\ to\\ get\\ a\\ ct\\ of\\ the\\ head\\?\\ depending\\ on\\ the\\ bx\\ results\\,\\ a\\ ct\\ may\\ be\\ helpful\\.\ \(0\)\
\-\ i\\ think\\ scc\\ and\\ primary\\ melanoma\\ are\\ very\\ high\\ on\\ the\\ differential\\ along\\ with\\ bcc\\;\\ i\\&\\#39\\;d\\ also\\ include\\ lymphoma\\/leukemia\\,\\ leiomyosarcoma\\/leiomyoma\\,\\ optic\\ nerve\\ tumor\\,\\ meningioma\\,\\ schwannoma\\,\\ neurofibroma\\,\\ lacrimal\\ tumors\\ etc\\,\\ vs\\ metastatic\\ lesion\\ \\(smoker\\?\\ lung\\)\\ or\\ paranasal\\ sinus\\ tumor\\ invasion\\.\ \(0\)\
\-\ lower\\ on\\ the\\ ddx\\:\\ sebaceous\\ cell\\ carcinoma\\,\\ other\\ adenocarcinoma\\,\\ granular\\ cell\\ tumor\\,\\ langerhans\\ histiocytosis\\,\\ fibrous\\ histiocytoma\\,\\ granulocytic\\ sarcoma\\,\\ myeloma\\,\\ osteosarcoma\\,\\ sarcoidosis\\,\\ amyloid\\ nodular\\,\\ hemangiopericytoma\\.\ \(0\)\
\-\ i\\ agree\\ it\\ will\\ be\\ filled\\ with\\ blood\\ vessels\\ feeding\\ this\\ growth\\,\\ \\(but\\ i\\ don\\&\\#39\\;t\\ think\\ it\\&\\#39\\;s\\ a\\ cavernous\\ hemangioma\\,\\ avm\\,\\ or\\ lymphangioma\\;\\ or\\ any\\ benign\\ cystic\\ lesion\\.\\)\\ i\\ don\\&\\#39\\;t\\ think\\ it\\&\\#39\\;s\\ an\\ infectious\\ mass\\ either\\.\ \(0\)\
\-\ based\\ on\\ the\\ bx\\ results\\,\\ as\\ dr\\ xx\\ suggested\\,\\ he\\ can\\ be\\ sent\\ to\\ oculoplastics\\ or\\ mohs\\ \\(dr\\ xxcc\\&\\#39\\;d\\ above\\)\\.\ \(0\)\
\-\ if\\ you\\ get\\ a\\ bx\\,\\ please\\ forward\\ the\\ results\\ to\\ me\\.\ \(0\)\
\-\ \\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\\-\ \(3\)\
\-\ 2nd\\ ophthalmologist\\&\\#39\\;s\\ recommendation\\ \\/\\ dx\ \(0\)\
\-\ this\\ is\\ a\\ very\\ unfortunate\\ case\\,\\ that\\ i\\ will\\ agree\\ with\\ you\\ on\\.\\.\\.very\\ little\\ to\\ do\\ other\\ than\\ palliative\\.\ \(0\)\
\-\ from\\ the\\ foto\\,\\ it\\ appears\\ that\\ the\\ lids\\ are\\ consumed\\ by\\ a\\ diffusely\\ infiltrative\\ neoplastic\\ process\\,\\ with\\ areas\\ of\\ marked\\ thickening\\,\\ ulceration\\ and\\ necrosis\\,\\ giving\\ the\\ appearance\\ of\\ a\\ rodent\\ ulcer\\.\\ in\\ the\\ us\\ this\\ would\\ most\\ typically\\ be\\ a\\ basal\\ cell\\ carcinoma\\ or\\ squamous\\ cell\\ ca\\.\\ in\\ your\\ region\\,\\ sebaceous\\ cell\\ ca\\ is\\ also\\ very\\ prevalent\\ and\\ may\\ actually\\ be\\ more\\ common\\ than\\ either\\ bcc\\ or\\ scc\\.\\ i\\ suspect\\ the\\ orbit\\ proper\\ is\\ probably\\ full\\ of\\ tumor\\ as\\ well\ \(0\)\
\-\ the\\ temporal\\ headaches\\ are\\ concerning\\ and\\ worrisome\\ for\\ perineural\\ spread\\,\\ which\\ would\\ lead\\ to\\ intracranial\\ extension\\.\ \(0\)\
\-\ the\\ clinical\\ foto\\ is\\ discouraging\\ \\ enough\\,\\ but\\ the\\ required\\ imaging\\ is\\ ct\\ to\\ evaluate\\ unseen\\ extent\\.\ \(0\)\
\-\ these\\ would\\ be\\ challenging\\ cases\\ even\\ here\\,\\ and\\ would\\ inevitably\\ require\\ orbital\\ exenteration\\ \\(possibly\\ including\\ bone\\ removal\\)\\ and\\ radiation\\.\\ the\\ surgical\\ team\\ would\\ typically\\ involve\\ oculoplastics\\,\\ neurosurgery\\,\\ and\\ ent\\.\\ i\\&\\#39\\;m\\ not\\ sure\\ you\\ have\\ the\\ capacity\\ for\\ that\\ level\\ of\\ care\\ even\\ at\\ the\\ american\\ role\\ 3\\&\\#39\\;s\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ \\-\\-\\:\\ 0\\.1877725882049004\ \(0\)\
\-\ i\\:\\ 0\\.04549439349880326\ \(0\)\
\-\ 39\\:\\ 0\\.0365347869135962\ \(0\)\
\-\ cell\\:\\ 0\\.03609944075150439\ \(0\)\
\-\ xx\\:\\ 0\\.03549634836843785\ \(0\)\
\-\ \\#\\:\\ 0\\.030834283522915253\ \(0\)\
\-\ ca\\:\\ 0\\.029286009324857556\ \(0\)\
\-\ \\&\\:\\ 0\\.027611664141135524\ \(0\)\
\-\ he\\:\\ 0\\.026320375441026896\ \(0\)\
\-\ it\\:\\ 0\\.024739537611280803\ \(0\)\
\-\ oculoplastics\\:\\ 0\\.024329857655841305\ \(0\)\
\-\ squamous\\:\\ 0\\.02307703460388333\ \(0\)\
\-\ would\\:\\ 0\\.022380621000346566\ \(0\)\
\-\ \\;\\:\\ 0\\.022359755530295424\ \(0\)\
\-\ basal\\:\\ 0\\.021502506889448245\ \(0\)\
\-\ agree\\:\\ 0\\.02050383825992624\ \(0\)\
\-\ states\\:\\ 0\\.018490008640155275\ \(0\)\
\-\ bx\\:\\ 0\\.018265760386284118\ \(0\)\
\-\ you\\:\\ 0\\.01819436030564345\ \(0\)\
\-\ carcinoma\\:\\ 0\\.017824674664330204\ \(0\)\
\-\ think\\:\\ 0\\.017471789625147647\ \(0\)\
\-\ could\\:\\ 0\\.01740142379299293\ \(0\)\
\-\ sebaceous\\:\\ 0\\.016855938057583134\ \(0\)\
\-\ \\,\\:\\ 0\\.016685901002445495\ \(0\)\
\-\ recommendation\\:\\ 0\\.01651050160048836\ \(0\)\
\-\ eye\\:\\ 0\\.016487625607690484\ \(0\)\
\-\ rodent\\:\\ 0\\.016219905103894202\ \(0\)\
\-\ leiomyosarcoma\\/leiomyoma\\:\\ 0\\.016219905103894202\ \(0\)\
\-\ yy\\:\\ 0\\.016219905103894202\ \(0\)\
\-\ mohs\\:\\ 0\\.016219905103894202\ \(0\)\
\-\ foto\\:\\ 0\\.016219905103894202\ \(0\)\
\-\ dr\\:\\ 0\\.015798921722009703\ \(0\)\
\-\ vs\\:\\ 0\\.015475988824290698\ \(0\)\
\-\ dx\\:\\ 0\\.015446115728882147\ \(0\)\
\-\ consumed\\:\\ 0\\.014944565305255847\ \(0\)\
\-\ granulocytic\\:\\ 0\\.014944565305255847\ \(0\)\
\-\ bcc\\:\\ 0\\.014944565305255847\ \(0\)\
\-\ tumor\\:\\ 0\\.014662243250125566\ \(0\)\
\-\ lids\\:\\ 0\\.014198539347375139\ \(0\)\
\-\ don\\:\\ 0\\.014198539347375139\ \(0\)\
\-\ os\\:\\ 0\\.014080808713695098\ \(0\)\
\-\ s\\:\\ 0\\.013527696414615938\ \(0\)\
\-\ lymphoma\\/leukemia\\:\\ 0\\.01239388570797914\ \(0\)\
\-\ \\?\\:\\ 0\\.012271865687670677\ \(0\)\
\-\ be\\:\\ 0\\.01212287693968656\ \(0\)\
\-\ melanoma\\:\\ 0\\.012036350858453516\ \(0\)\
\-\ but\\:\\ 0\\.011736451800583959\ \(0\)\
\-\ ophthalmologist\\:\\ 0\\.011647859750098431\ \(0\)\
\-\ \\/\\:\\ 0\\.011647834150410052\ \(0\)\
\-\ surgery\\:\\ 0\\.011453536693800967\ \(0\)\
\-\ very\\:\\ 0\\.011414114511341781\ \(0\)\
\-\ suspect\\:\\ 0\\.011237292038388753\ \(0\)\
\-\ scc\\:\\ 0\\.011237292038388753\ \(0\)\
\-\ lesion\\:\\ 0\\.011208727306350674\ \(0\)\
\-\ able\\:\\ 0\\.011116908963710542\ \(0\)\
\-\ granular\\:\\ 0\\.010901833792217725\ \(0\)\
\-\ lacrimal\\:\\ 0\\.010707978197631108\ \(0\)\
\-\ paranasal\\:\\ 0\\.010707978197631108\ \(0\)\
\-\ your\\:\\ 0\\.010532614481339802\ \(0\)\
\-\ tested\\:\\ 0\\.010450826509728332\ \(0\)\
\-\ periorbital\\:\\ 0\\.010450826509728332\ \(0\)\
\-\ unremarkable\\:\\ 0\\.01041054799883003\ \(0\)\
\-\ histiocytoma\\:\\ 0\\.010372519951460078\ \(0\)\
\-\ giving\\:\\ 0\\.01029741048592143\ \(0\)\
\-\ amyloid\\:\\ 0\\.010155807834337017\ \(0\)\
\-\ ulceration\\:\\ 0\\.00967832633390448\ \(0\)\
\-\ get\\:\\ 0\\.009626493993579371\ \(0\)\
\-\ palliative\\:\\ 0\\.009576081897557081\ \(0\)\
\-\ results\\:\\ 0\\.009520356234437848\ \(0\)\
\-\ that\\:\\ 0\\.009504935694491044\ \(0\)\
\-\ hemangiopericytoma\\:\\ 0\\.009387205809130064\ \(0\)\
\-\ smoker\\:\\ 0\\.009342868087733448\ \(0\)\
\-\ langerhans\\:\\ 0\\.00929957370427403\ \(0\)\
\-\ 1st\\:\\ 0\\.009257274682701447\ \(0\)\
\-\ myeloma\\:\\ 0\\.009135916876276799\ \(0\)\
\-\ infiltrative\\:\\ 0\\.009022070687283076\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.0087489888011409\ \(0\)\
\-\ neurofibroma\\:\\ 0\\.008717536301859757\ \(0\)\
\-\ ulcer\\:\\ 0\\.008656199742029783\ \(0\)\
\-\ slowly\\:\\ 0\\.008539339749900388\ \(0\)\
\-\ if\\:\\ 0\\.008532634530931501\ \(0\)\
\-\ have\\:\\ 0\\.008511674693491683\ \(0\)\
\-\ etc\\:\\ 0\\.00851124872482074\ \(0\)\
\-\ \\:\\:\\ 0\\.008318489906095052\ \(0\)\
\-\ ddx\\:\\ 0\\.008300742098918727\ \(0\)\
\-\ we\\:\\ 0\\.00827604472940237\ \(0\)\
\-\ to\\:\\ 0\\.008250625830085291\ \(0\)\
\-\ osteosarcoma\\:\\ 0\\.008180442633853683\ \(0\)\
\-\ v\\/s\\:\\ 0\\.008109952551947101\ \(0\)\
\-\ eye\\-\\:\\ 0\\.008109952551947101\ \(0\)\
\-\ snellen\\:\\ 0\\.008109952551947101\ \(0\)\
\-\ wrinkle\\:\\ 0\\.008109952551947101\ \(0\)\
\-\ vacularity\\:\\ 0\\.008109952551947101\ \(0\)\
\-\ 60\\+\\:\\ 0\\.008109952551947101\ \(0\)\
\-\ debulked\\:\\ 0\\.008109952551947101\ \(0\)\
\-\ generous\\:\\ 0\\.008109952551947101\ \(0\)\
\-\ capabilities\\:\\ 0\\.008109952551947101\ \(0\)\
\-\ xxcc\\:\\ 0\\.008109952551947101\ \(0\)\
\-\ discouraging\\:\\ 0\\.008109952551947101\ \(0\)\
\-\ unseen\\:\\ 0\\.008109952551947101\ \(0\)\
\-\ sure\\:\\ 0\\.008109952551947101\ \(0\)\
\-\ neoplastic\\:\\ 0\\.008045753758005854\ \(0\)\
\-\ advanced\\:\\ 0\\.008045753758005854\ \(0\)\
\-\ diffusely\\:\\ 0\\.00794058648323134\ \(0\)\
\-\ orbit\\:\\ 0\\.007920255597883438\ \(0\)\
\-\ d\\:\\ 0\\.007841106775282351\ \(0\)\
\-\ ear\\:\\ 0\\.007746730888644722\ \(0\)\
\-\ invasion\\:\\ 0\\.007571367172353416\ \(0\)\
\-\ x\\-\\:\\ 0\\.007472282652627923\ \(0\)\
\-\ chances\\:\\ 0\\.007472282652627923\ \(0\)\
\-\ slim\\:\\ 0\\.007472282652627923\ \(0\)\
\-\ metastasizes\\:\\ 0\\.007472282652627923\ \(0\)\
\-\ inevitably\\:\\ 0\\.007472282652627923\ \(0\)\
\-\ any\\:\\ 0\\.007426407634974132\ \(0\)\
\-\ filled\\:\\ 0\\.00730695738271924\ \(0\)\
\-\ optic\\:\\ 0\\.007278207947754969\ \(0\)\
\-\ t\\:\\ 0\\.007278207947754969\ \(0\)\
\-\ schwannoma\\:\\ 0\\.0071809816710771785\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.0071015480521899495\ \(0\)\
\-\ gauze\\:\\ 0\\.007099269673687569\ \(0\)\
\-\ exam\\-\\:\\ 0\\.007099269673687569\ \(0\)\
\-\ vii\\-\\:\\ 0\\.007099269673687569\ \(0\)\
\-\ smile\\:\\ 0\\.007099269673687569\ \(0\)\
\-\ interpreter\\:\\ 0\\.007099269673687569\ \(0\)\
\-\ collect\\:\\ 0\\.007099269673687569\ \(0\)\
\-\ sarcoma\\:\\ 0\\.007000704930764015\ \(0\)\
\-\ even\\:\\ 0\\.007000704930764015\ \(0\)\
\-\ either\\:\\ 0\\.006847779619429137\ \(0\)\
\-\ ix\\:\\ 0\\.0068346127533087464\ \(0\)\
\-\ cerumen\\:\\ 0\\.0068346127533087464\ \(0\)\
\-\ palatal\\:\\ 0\\.0068346127533087464\ \(0\)\
\-\ metastasized\\:\\ 0\\.0068346127533087464\ \(0\)\
\-\ somewhere\\:\\ 0\\.0068346127533087464\ \(0\)\
\-\ do\\:\\ 0\\.006825341214472709\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.006792188490456741\ \(0\)\
\-\ send\\:\\ 0\\.0066293288974539075\ \(0\)\
\-\ dermatologist\\:\\ 0\\.0066293288974539075\ \(0\)\
\-\ nodular\\:\\ 0\\.006595050243076194\ \(0\)\
\-\ a\\:\\ 0\\.0065674300209152\ \(0\)\
\-\ pictured\\:\\ 0\\.0064615997743683925\ \(0\)\
\-\ camp\\:\\ 0\\.0064615997743683925\ \(0\)\
\-\ exenteration\\:\\ 0\\.0064615997743683925\ \(0\)\
\-\ or\\:\\ 0\\.006449548521385421\ \(0\)\
\-\ was\\:\\ 0\\.006364252672949225\ \(0\)\
\-\ fibrous\\:\\ 0\\.006355522094309242\ \(0\)\
\-\ resources\\:\\ 0\\.0063197868214454325\ \(0\)\
\-\ unfortunate\\:\\ 0\\.0063197868214454325\ \(0\)\
\-\ temporal\\:\\ 0\\.006296027373715063\ \(0\)\
\-\ necrosis\\:\\ 0\\.006206257062455758\ \(0\)\
\-\ a\\/p\\:\\ 0\\.00619694285398957\ \(0\)\
\-\ traveled\\:\\ 0\\.00619694285398957\ \(0\)\
\-\ looks\\:\\ 0\\.00619694285398957\ \(0\)\
\-\ try\\:\\ 0\\.00619694285398957\ \(0\)\
\-\ me\\:\\ 0\\.00619694285398957\ \(0\)\
\-\ perineural\\:\\ 0\\.00619694285398957\ \(0\)\
\-\ marked\\:\\ 0\\.006135932843835339\ \(0\)\
\-\ nothing\\:\\ 0\\.0060885867954280385\ \(0\)\
\-\ process\\:\\ 0\\.006053478352961756\ \(0\)\
\-\ meningioma\\:\\ 0\\.006046162532576034\ \(0\)\
\-\ headaches\\:\\ 0\\.006010013503351018\ \(0\)\
\-\ va\\:\\ 0\\.005991658998134731\ \(0\)\
\-\ viii\\:\\ 0\\.005991658998134731\ \(0\)\
\-\ transport\\:\\ 0\\.005991658998134731\ \(0\)\
\-\ bleeds\\:\\ 0\\.005991658998134731\ \(0\)\
\-\ challenging\\:\\ 0\\.005991658998134731\ \(0\)\
\-\ tumors\\:\\ 0\\.005905641872438824\ \(0\)\
\-\ meet\\:\\ 0\\.005903977139989078\ \(0\)\
\-\ prevalent\\:\\ 0\\.005903977139989078\ \(0\)\
\-\ worrisome\\:\\ 0\\.005903977139989078\ \(0\)\
\-\ capacity\\:\\ 0\\.005903977139989078\ \(0\)\
\-\ appears\\:\\ 0\\.005852306937989418\ \(0\)\
\-\ objects\\:\\ 0\\.005823929875049216\ \(0\)\
\-\ pshx\\:\\ 0\\.005823929875049216\ \(0\)\
\-\ rx\\:\\ 0\\.005823929875049216\ \(0\)\
\-\ vi\\:\\ 0\\.005750293529443387\ \(0\)\
\-\ sinus\\:\\ 0\\.00575006250164202\ \(0\)\
\-\ is\\:\\ 0\\.005690155071050581\ \(0\)\
\-\ care\\:\\ 0\\.005670979111442047\ \(0\)\
\-\ nerve\\:\\ 0\\.0056650342713657886\ \(0\)\
\-\ noted\\:\\ 0\\.005589938882573856\ \(0\)\
\-\ biopsy\\:\\ 0\\.005578092440914003\ \(0\)\
\-\ debulking\\:\\ 0\\.005559272954670393\ \(0\)\
\-\ nkda\\:\\ 0\\.005559272954670393\ \(0\)\
\-\ typically\\:\\ 0\\.005550001415834355\ \(0\)\
\-\ mass\\:\\ 0\\.005466701963880241\ \(0\)\
\-\ od\\:\\ 0\\.0054509168961088626\ \(0\)\
\-\ other\\:\\ 0\\.005435984955020558\ \(0\)\
\-\ small\\:\\ 0\\.0054330504628733725\ \(0\)\
\-\ bump\\:\\ 0\\.005401177042134368\ \(0\)\
\-\ enucleation\\:\\ 0\\.005401177042134368\ \(0\)\
\-\ are\\:\\ 0\\.005358205485416751\ \(0\)\
\-\ thickening\\:\\ 0\\.005329576025194759\ \(0\)\
\-\ told\\:\\ 0\\.005309103943185902\ \(0\)\
\-\ areas\\:\\ 0\\.005290427178005643\ \(0\)\
\-\ curative\\:\\ 0\\.005266307240669901\ \(0\)\
\-\ today\\:\\ 0\\.005148705242960715\ \(0\)\
\-\ forehead\\:\\ 0\\.005112623630124209\ \(0\)\
\-\ had\\:\\ 0\\.005088821948226426\ \(0\)\
\-\ symmetrical\\:\\ 0\\.005077903917168509\ \(0\)\
\-\ occluded\\:\\ 0\\.005077903917168509\ \(0\)\
\-\ grew\\:\\ 0\\.005077903917168509\ \(0\)\
\-\ lymphangioma\\:\\ 0\\.005077903917168509\ \(0\)\
\-\ basic\\:\\ 0\\.0050121642998896265\ \(0\)\
\-\ refer\\:\\ 0\\.0050121642998896265\ \(0\)\
\-\ access\\:\\ 0\\.0049809761198752\ \(0\)\
\-\ \\.\\.\\.\\:\\ 0\\.0049809761198752\ \(0\)\
\-\ will\\:\\ 0\\.0049190083134850815\ \(0\)\
\-\ forward\\:\\ 0\\.004893294261729547\ \(0\)\
\-\ actually\\:\\ 0\\.00483916316695224\ \(0\)\
\-\ proper\\:\\ 0\\.00483916316695224\ \(0\)\
\-\ medical\\:\\ 0\\.004837736522660541\ \(0\)\
\-\ tongue\\:\\ 0\\.0047880409487785405\ \(0\)\
\-\ morbidity\\:\\ 0\\.0047880409487785405\ \(0\)\
\-\ success\\:\\ 0\\.0047880409487785405\ \(0\)\
\-\ remove\\:\\ 0\\.0047880409487785405\ \(0\)\
\-\ team\\:\\ 0\\.004716319199496377\ \(0\)\
\-\ ent\\:\\ 0\\.004716319199496377\ \(0\)\
\-\ enough\\:\\ 0\\.004693602904565032\ \(0\)\
\-\ attached\\:\\ 0\\.004671434043866724\ \(0\)\
\-\ already\\:\\ 0\\.004671434043866724\ \(0\)\
\-\ on\\:\\ 0\\.0046616716527672466\ \(0\)\
\-\ primary\\:\\ 0\\.00465756074129843\ \(0\)\
\-\ \\(\\:\\ 0\\.004651823444072699\ \(0\)\
\-\ pmhx\\:\\ 0\\.004649786852137015\ \(0\)\
\-\ role\\:\\ 0\\.004649786852137015\ \(0\)\
\-\ picture\\:\\ 0\\.004607963140934847\ \(0\)\
\-\ the\\:\\ 0\\.004578633164057524\ \(0\)\
\-\ lung\\:\\ 0\\.00455411061681462\ \(0\)\
\-\ his\\:\\ 0\\.004531534549488375\ \(0\)\
\-\ take\\:\\ 0\\.004511035343641538\ \(0\)\
\-\ appearance\\:\\ 0\\.004496608236862266\ \(0\)\
\-\ likely\\:\\ 0\\.004434756147075725\ \(0\)\
\-\ has\\:\\ 0\\.004428794766773537\ \(0\)\
\-\ neurosurgery\\:\\ 0\\.004423353485495885\ \(0\)\
\-\ v\\:\\ 0\\.004313140790176087\ \(0\)\
\-\ high\\:\\ 0\\.004302752642275649\ \(0\)\
\-\ appeared\\:\\ 0\\.004283933156032038\ \(0\)\
\-\ mortality\\:\\ 0\\.004283933156032038\ \(0\)\
\-\ stated\\:\\ 0\\.004283933156032038\ \(0\)\
\-\ been\\:\\ 0\\.004277451498553801\ \(0\)\
\-\ little\\:\\ 0\\.004269669874950194\ \(0\)\
\-\ cn\\:\\ 0\\.004228160734857766\ \(0\)\
\-\ progressively\\:\\ 0\\.004228160734857766\ \(0\)\
\-\ due\\:\\ 0\\.004195542139747635\ \(0\)\
\-\ probably\\:\\ 0\\.004188443925414152\ \(0\)\
\-\ what\\:\\ 0\\.004150371049459364\ \(0\)\
\-\ grossly\\:\\ 0\\.004125837243496014\ \(0\)\
\-\ concerning\\:\\ 0\\.004125837243496014\ \(0\)\
\-\ than\\:\\ 0\\.004119685105645398\ \(0\)\
\-\ here\\:\\ 0\\.004101940751864679\ \(0\)\
\-\ minimally\\:\\ 0\\.004090221316926841\ \(0\)\
\-\ depending\\:\\ 0\\.004090221316926841\ \(0\)\
\-\ helpful\\:\\ 0\\.004067221038908978\ \(0\)\
\-\ neuro\\:\\ 0\\.004055933005245855\ \(0\)\
\-\ m\\:\\ 0\\.004055933005245855\ \(0\)\
\-\ feeding\\:\\ 0\\.004033764144547547\ \(0\)\
\-\ returned\\:\\ 0\\.004022876879002927\ \(0\)\
\-\ possibly\\:\\ 0\\.004022876879002927\ \(0\)\
\-\ suggested\\:\\ 0\\.004001481421630097\ \(0\)\
\-\ sent\\:\\ 0\\.004001481421630097\ \(0\)\
\-\ surgically\\:\\ 0\\.003980572267004929\ \(0\)\
\-\ metastatic\\:\\ 0\\.003957882987334112\ \(0\)\
\-\ \\)\\:\\ 0\\.0039385705176447385\ \(0\)\
\-\ movement\\:\\ 0\\.003930288538819222\ \(0\)\
\-\ need\\:\\ 0\\.0039205533876411755\ \(0\)\
\-\ 2nd\\:\\ 0\\.0039205533876411755\ \(0\)\
\-\ extent\\:\\ 0\\.003901386794354292\ \(0\)\
\-\ none\\:\\ 0\\.0039001278875952284\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.003864093905486324\ \(0\)\
\-\ spread\\:\\ 0\\.003802564118530155\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.003789787492147641\ \(0\)\
\-\ rarely\\:\\ 0\\.0037691072241687242\ \(0\)\
\-\ lead\\:\\ 0\\.0037691072241687242\ \(0\)\
\-\ avm\\:\\ 0\\.0037447896003709735\ \(0\)\
\-\ american\\:\\ 0\\.0037447896003709735\ \(0\)\
\-\ painful\\:\\ 0\\.003736824501251273\ \(0\)\
\-\ orbital\\:\\ 0\\.0037289277729243256\ \(0\)\
\-\ involve\\:\\ 0\\.0037056363212368466\ \(0\)\
\-\ iii\\:\\ 0\\.003690429971695714\ \(0\)\
\-\ imaging\\:\\ 0\\.0036836684902586984\ \(0\)\
\-\ cavernous\\:\\ 0\\.0036462632567128618\ \(0\)\
\-\ like\\:\\ 0\\.0036391039738774846\ \(0\)\
\-\ sensation\\:\\ 0\\.0036110113116326996\ \(0\)\
\-\ local\\:\\ 0\\.0036110113116326996\ \(0\)\
\-\ having\\:\\ 0\\.0036110113116326996\ \(0\)\
\-\ require\\:\\ 0\\.003597280262675316\ \(0\)\
\-\ l\\:\\ 0\\.0035837511482413736\ \(0\)\
\-\ r\\:\\ 0\\.003570418114844348\ \(0\)\
\-\ as\\:\\ 0\\.0035673712214189363\ \(0\)\
\-\ glioma\\:\\ 0\\.003544318117485364\ \(0\)\
\-\ removed\\:\\ 0\\.003544318117485364\ \(0\)\
\-\ poor\\:\\ 0\\.0035379071981513316\ \(0\)\
\-\ lower\\:\\ 0\\.0035360847642389374\ \(0\)\
\-\ hemangioma\\:\\ 0\\.0035127011501401868\ \(0\)\
\-\ there\\:\\ 0\\.0035097945440616066\ \(0\)\
\-\ please\\:\\ 0\\.003488167344176837\ \(0\)\
\-\ may\\:\\ 0\\.0034486262537223988\ \(0\)\
\-\ growth\\:\\ 0\\.0034182631059266784\ \(0\)\
\-\ 18\\:\\ 0\\.0034126706072363545\ \(0\)\
\-\ not\\:\\ 0\\.003407963215479123\ \(0\)\
\-\ absent\\:\\ 0\\.003407111900285147\ \(0\)\
\-\ full\\:\\ 0\\.0033960942452283707\ \(0\)\
\-\ ii\\:\\ 0\\.0033906345069396734\ \(0\)\
\-\ infectious\\:\\ 0\\.0033798112856153065\ \(0\)\
\-\ stage\\:\\ 0\\.00335329754271237\ \(0\)\
\-\ intracranial\\:\\ 0\\.0033224578996225414\ \(0\)\
\-\ ct\\:\\ 0\\.003298906127116954\ \(0\)\
\-\ us\\:\\ 0\\.003297525121538097\ \(0\)\
\-\ around\\:\\ 0\\.0032732502777725087\ \(0\)\
\-\ done\\:\\ 0\\.0032589869966906638\ \(0\)\
\-\ 12\\:\\ 0\\.0032174778565982353\ \(0\)\
\-\ pathology\\:\\ 0\\.0032174778565982353\ \(0\)\
\-\ where\\:\\ 0\\.003208502534661377\ \(0\)\
\-\ evaluate\\:\\ 0\\.003177761047154621\ \(0\)\
\-\ vessels\\:\\ 0\\.003164894219210978\ \(0\)\
\-\ patient\\:\\ 0\\.0031521322204834884\ \(0\)\
\-\ canal\\:\\ 0\\.003123259820325862\ \(0\)\
\-\ use\\:\\ 0\\.0031071197010517962\ \(0\)\
\-\ in\\:\\ 0\\.0031013595594498984\ \(0\)\
\-\ also\\:\\ 0\\.003099576069310306\ \(0\)\
\-\ removal\\:\\ 0\\.0030991546019320955\ \(0\)\
\-\ worsening\\:\\ 0\\.0030951977648581395\ \(0\)\
\-\ based\\:\\ 0\\.0029978752182768724\ \(0\)\
\-\ referred\\:\\ 0\\.002966450269968391\ \(0\)\
\-\ hospital\\:\\ 0\\.002959610363356139\ \(0\)\
\-\ sided\\:\\ 0\\.0029066482181661873\ \(0\)\
\-\ involvement\\:\\ 0\\.0028812683133650563\ \(0\)\
\-\ above\\:\\ 0\\.0028812683133650563\ \(0\)\
\-\ iv\\:\\ 0\\.0028688361890166457\ \(0\)\
\-\ reported\\:\\ 0\\.0028657542323604524\ \(0\)\
\-\ including\\:\\ 0\\.0028384716108490558\ \(0\)\
\-\ required\\:\\ 0\\.002829554288672736\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.0028177974104331787\ \(0\)\
\-\ extension\\:\\ 0\\.002806188887931604\ \(0\)\
\-\ then\\:\\ 0\\.002797577625043321\ \(0\)\
\-\ benign\\:\\ 0\\.002713017816957867\ \(0\)\
\-\ presentation\\:\\ 0\\.002707820270920959\ \(0\)\
\-\ given\\:\\ 0\\.002694953442977316\ \(0\)\
\-\ less\\:\\ 0\\.002662318311244418\ \(0\)\
\-\ this\\:\\ 0\\.0026526326034428697\ \(0\)\
\-\ and\\:\\ 0\\.002649626579315083\ \(0\)\
\-\ first\\:\\ 0\\.0026379792408333506\ \(0\)\
\-\ cases\\:\\ 0\\.0026189612364131854\ \(0\)\
\-\ by\\:\\ 0\\.002617977742860855\ \(0\)\
\-\ along\\:\\ 0\\.0025980256456840075\ \(0\)\
\-\ cancer\\:\\ 0\\.002584328670068781\ \(0\)\
\-\ bilaterally\\:\\ 0\\.0025820655368205183\ \(0\)\
\-\ radiation\\:\\ 0\\.0025798079572790585\ \(0\)\
\-\ differential\\:\\ 0\\.002495823210076292\ \(0\)\
\-\ area\\:\\ 0\\.0024855899210066857\ \(0\)\
\-\ approximately\\:\\ 0\\.002432215111826663\ \(0\)\
\-\ clinical\\:\\ 0\\.0024188682613302706\ \(0\)\
\-\ some\\:\\ 0\\.0023872385040172575\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.0023496106160491776\ \(0\)\
\-\ see\\:\\ 0\\.0023461059900908815\ \(0\)\
\-\ from\\:\\ 0\\.0023301485062635\ \(0\)\
\-\ cystic\\:\\ 0\\.002267371395815785\ \(0\)\
\-\ level\\:\\ 0\\.0022657672747441876\ \(0\)\
\-\ head\\:\\ 0\\.0022296240207671536\ \(0\)\
\-\ all\\:\\ 0\\.0022234806710499455\ \(0\)\
\-\ region\\:\\ 0\\.002220424312087684\ \(0\)\
\-\ include\\:\\ 0\\.0022052929972679733\ \(0\)\
\-\ y\\/o\\:\\ 0\\.0021772116189693108\ \(0\)\
\-\ an\\:\\ 0\\.0021741763832285738\ \(0\)\
\-\ months\\:\\ 0\\.0021471401055106415\ \(0\)\
\-\ blood\\:\\ 0\\.002145732357414259\ \(0\)\
\-\ at\\:\\ 0\\.0021301989932504747\ \(0\)\
\-\ common\\:\\ 0\\.002057283543658139\ \(0\)\
\-\ these\\:\\ 0\\.002045855282389917\ \(0\)\
\-\ anterior\\:\\ 0\\.0020246484119252413\ \(0\)\
\-\ prior\\:\\ 0\\.002018503010305762\ \(0\)\
\-\ for\\:\\ 0\\.0020122579999338965\ \(0\)\
\-\ over\\:\\ 0\\.002001511122483866\ \(0\)\
\-\ more\\:\\ 0\\.001966123559624808\ \(0\)\
\-\ bone\\:\\ 0\\.0019534817676723736\ \(0\)\
\-\ into\\:\\ 0\\.0018705854351055262\ \(0\)\
\-\ 3\\:\\ 0\\.001840823851615952\ \(0\)\
\-\ most\\:\\ 0\\.0018149357329605115\ \(0\)\
\-\ can\\:\\ 0\\.0017830932405419222\ \(0\)\
\-\ well\\:\\ 0\\.001778363342197471\ \(0\)\
\-\ left\\:\\ 0\\.001759163328929006\ \(0\)\
\-\ exam\\:\\ 0\\.0017269861453077628\ \(0\)\
\-\ case\\:\\ 0\\.00171987528322656\ \(0\)\
\-\ large\\:\\ 0\\.0017189902776734863\ \(0\)\
\-\ \\.\\:\\ 0\\.0016982298777019377\ \(0\)\
\-\ surgical\\:\\ 0\\.0016524579303141248\ \(0\)\
\-\ no\\:\\ 0\\.0015831539111385501\ \(0\)\
\-\ which\\:\\ 0\\.0014674743212902933\ \(0\)\
\-\ male\\:\\ 0\\.0014215322335671325\ \(0\)\
\-\ with\\:\\ 0\\.0012916744370549006\ \(0\)\
\-\ history\\:\\ 0\\.0010857539445327355\ \(0\)\
\-\ of\\:\\ 0\\.0010717920956576671\ \(0\)\
\-\ right\\:\\ 0\\.0008294679936618369\ \(0\)\
